CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 448 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,042,653 | -64.7% | 74,850 | -43.2% | 0.32% | -22.2% |
Q3 2022 | $8,616,000 | -5.5% | 131,850 | -12.1% | 0.41% | 0.0% |
Q2 2022 | $9,116,000 | -3.2% | 150,000 | 0.0% | 0.41% | +17.8% |
Q1 2022 | $9,416,000 | -17.2% | 150,000 | 0.0% | 0.35% | -13.4% |
Q4 2021 | $11,367,000 | -16.8% | 150,000 | +23.0% | 0.40% | -24.7% |
Q3 2021 | $13,655,000 | -4.1% | 122,000 | +38.6% | 0.53% | -0.7% |
Q2 2021 | $14,246,000 | +46.1% | 88,000 | +10.0% | 0.54% | +58.7% |
Q1 2021 | $9,748,000 | +70.7% | 80,000 | +114.5% | 0.34% | +31.9% |
Q4 2020 | $5,711,000 | +113.4% | 37,300 | +16.6% | 0.26% | +131.5% |
Q3 2020 | $2,676,000 | +13.8% | 32,000 | 0.0% | 0.11% | -14.6% |
Q2 2020 | $2,352,000 | +73.3% | 32,000 | 0.0% | 0.13% | +32.7% |
Q1 2020 | $1,357,000 | -3.1% | 32,000 | +39.1% | 0.10% | +27.3% |
Q4 2019 | $1,401,000 | +55.3% | 23,000 | +4.5% | 0.08% | +45.3% |
Q3 2019 | $902,000 | -12.9% | 22,000 | 0.0% | 0.05% | -11.7% |
Q2 2019 | $1,036,000 | -94.0% | 22,000 | +3459.9% | 0.06% | -11.8% |
Q1 2019 | $17,300,000 | +4626.8% | 618 | -95.2% | 0.07% | +172.0% |
Q4 2018 | $366,000 | +9.9% | 12,800 | +70.7% | 0.02% | +31.6% |
Q3 2018 | $333,000 | -24.5% | 7,500 | 0.0% | 0.02% | -29.6% |
Q2 2018 | $441,000 | – | 7,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |